MedTrace Logo

Healing Sounds for Pregnant Women: Sape' Dayak Music and Anxiety Reduction

NCT07078097 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-07-22

No results posted yet for this study

Summary

This study investigates whether listening to traditional Dayak Sape' music could reduce anxiety in pregnant women as effectively as traditional lullabies. The researchers will recruit 32 pregnant women and divide them into two groups: one listened to Sape' Dayak music, and the other listened to Brahms' Lullaby. Anxiety levels will be measured before and after the music interventions using the Perinatal Anxiety Screening Scale (PASS).

Conditions

Interventions

OTHER

Traditional Sape' Dayak Music Listening

This intervention is distinguished by its use of the Sape' Dayak, a specific traditional musical instrument from East Kalimantan, Indonesia, known for its gentle, contemplative, and culturally significant sounds. The music utilizes pentatonic melodies that foster a serene and emotionally relaxing environment. Its distinct rhythm (80-85 beats per minute) is also a key feature. The intervention also incorporates a gentle abdominal massage and imagining the infant.

OTHER

Brahms' Lullaby Music Therapy

This intervention is distinguished by its use of a globally popular and well-known lullaby composed by Johannes Brahms. The lyrics typically revolve around themes of love and affection, expressing mothers' love and tenderness for their fetuses. Unlike the Sape' Dayak, the specific lullaby will be preselected by the researcher to ensure a homogeneous intervention, with personal lullaby preferences ignored to avoid bias. Participants also engage in gentle abdominal touching and reflection on their unborn children.

Sponsors & Collaborators

  • Health Polytechnic of Palangka Raya

    lead OTHER

Principal Investigators

  • Erina Eka Hatini, Master · Health Polytechnic of Palangkaraya

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2025-04-30
Completion
2025-05-04

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07078097 on ClinicalTrials.gov